Last updated 2026-07-20
- Acquired by XTL Biopharmaceuticals Ltd., Jun 2026
- Raised Undisclosed Round led by NFX Capital, Aug 2021
Total raised
—
Last: Undisclosed Round 2021-09
Stage
Seed
Founded
2021
Headcount
3
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences
About
PsygaBio is a drug discovery company focused on developing groundbreaking therapeutics derived from natural compounds. Founded by Professor Dedi Meiri from the Technion – Israel Institute of Technology, the company uses Cannasoul's proprietary analytical platform, a data-driven approach, and unique know-how to support active compound identification and development, from mushroom cultivation and extraction through clinically approved formulations.
Funding history · 1 round · — total
2021-08
Undisclosed Round
Undisclosed
★ NFX Capital
Headcount over time
From 4 (2022-12) to 6 (2025-04) · +2 (+50%) · 5 points · source: Finder history + radar grounding
Q&A
- What is PsygaBio's primary focus?
- PsygaBio is a drug discovery company focused on developing therapeutics derived from natural compounds.
- When was PsygaBio founded?
- PsygaBio was founded in April 2021.
- Who is the Co-founder and CEO of PsygaBio?
- Shmuel Mandel is the Co-founder and CEO of PsygaBio.
- What is PsygaBio's current stage of funding?
- PsygaBio is currently in the Seed stage.
- Which investor participated in PsygaBio's funding round in September 2021?
- NFX Capital participated in PsygaBio's funding round in September 2021.
- What is PsygaBio's relationship with Cannasoul Analytics?
- PsygaBio is a subsidiary of Cannasoul Analytics and partners with them to identify active compounds and formulations from psychedelic mushrooms.
- Where is PsygaBio headquartered?
- PsygaBio is headquartered in Caesarea, Israel.
Team · 2
Shmuel Mandel
Founder · Co-founder & CEO
Dedi Meiri
Founder · Scientific Founder and Leader
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsCellsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
geneticspharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cannasoul.co.il/psyga-bio/ |
|---|---|
| linkedin.com/company/86858667 |
Identifiers & details
| Legal name | Psyga Bio Ltd. |
|---|---|
| Founded | 2021-4 |
| Employees (exact) | 3 |
Acquisitions & public offerings
Acquired by XTL Biopharmaceuticals Ltd. 2026-06
Radar intelligence
Web history (Wayback)
| Domain | cannasoul.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516387107 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-04-28 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 5 — shares_capital (2), people (2), other (1) |
| Registered address | תרשיש-פארק התעשייה 9 קיסריה |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-26 | הגדלה של הון רשום |
| 2026-06-25 | עדכון בעלי תפקידים |
| 2026-06-25 | עדכון דירקטורים-הוספת דירקטור |
| 2026-06-18 | הקצאת מניות |
| 2026-07-02 | שינוי בתקנון |